Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-010619
Filing Date
2023-02-03
Accepted
2023-02-03 17:11:05
Documents
1
Period of Report
2023-02-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm235353d2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm235353d2_4seq1.xml 4 5955
  Complete submission text file 0001104659-23-010619.txt   7634
Mailing Address 325 CENTRAL PARK W APT 38 NEW YORK NY 10025
Business Address
SCHEINBERG DAVID A (Reporting) CIK: 0001250316 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 23587186

Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations